1. Home
  2. TRNS vs ESPR Comparison

TRNS vs ESPR Comparison

Compare TRNS & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcat Inc.

TRNS

Transcat Inc.

HOLD

Current Price

$88.86

Market Cap

861.5M

Sector

Industrials

ML Signal

HOLD

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNS
ESPR
Founded
1964
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
861.5M
816.9M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
TRNS
ESPR
Price
$88.86
$3.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$116.00
$8.75
AVG Volume (30 Days)
178.4K
8.9M
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.71
EPS
0.57
N/A
Revenue
$331,877,000.00
$403,135,000.00
Revenue This Year
$21.75
N/A
Revenue Next Year
$7.55
$12.81
P/E Ratio
$156.19
N/A
Revenue Growth
19.20
21.31
52 Week Low
$50.23
$1.10
52 Week High
$94.76
$4.18

Technical Indicators

Market Signals
Indicator
TRNS
ESPR
Relative Strength Index (RSI) 51.54 64.86
Support Level $86.10 $3.13
Resistance Level $94.48 $3.18
Average True Range (ATR) 3.75 0.02
MACD -0.58 -0.01
Stochastic Oscillator 28.98 75.00

Price Performance

Historical Comparison
TRNS
ESPR

About TRNS Transcat Inc.

Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: